President of the All-Russian Society of Neurologists, Academician of the Russian Academy of Scinces, Professor E.I.Gusev
At the 14-16 of September, 2018 in Ekaterinburg, the third RUCTRIMS Congress on Multiple Sclerosis and other Demyelinating Diseases will be organized. There has been significant progress in understanding of the etiology and pathogenetic mechanisms of multiple sclerosis (MS) and other demyelinating diseases. Achievements of Experimental Neurology, Neurophysiology, Clinical Immunology and Genetics, standardization of diagnostic criterias, active implementation in everyday practice highly informative instrumental methods of examination of patients, including magnetic resonance imaging (MRI), the accumulation and systematization of the vast clinical experience, have opened a new era in the treatment of this chronic disease of the young adults, significantly improve the prognosis and the quality of life of patients. Expanded number of treatments that modify the course of multiple sclerosis (DMT) have now new first and second-line DMTs. Actively introduced biosimilars of original products increased the availability of this long term treatment. There are new ways of symptomatic treatment and rehabilitation. The decision to hold the third All-Russian Congress with international participation on MS and other demyelinating diseases was supported by the Ministry of Health of the Russian Federation, and this event is one of the most significant scientific and practical activities carried out in accordance with the plan of the Ministry of Health in 2018. The Congress will include the European Charcot Foundation Symposium and the joint symposium with the MS Patients Society of Russia (MSPSR). Conducting this Congress will improve the quality of specialized medical care for a large group of patients with MS. The Congress will be attended by more than 500 delegates and guests from all regions of the Russian Federation, experts in MS from Europe, North America, Asia, Australia and other regions. In the name and on behalf of the Presidium of the Board of the All-Russian Society of Neurologists we invite you to take part in the third RUCTRIMS Congress.
President of the RUCTRIMS, Professor A.N.Boyko
The problem of multiple sclerosis (MS) and other demyelinating diseases is one of the most important for modern neurology. In Ekaterinburg, the Third Congress of multiple sclerosis and other demyelinating diseases, organized by the All-Russian Society of Neurologists (RSN) and the Russian Committee of Explorers Multiple Sclerosis (RUCTRIMS) will be held. Organized at many regions professional societies of specialists in MS are working in close collaboration with professional organizations neurologists and MS patients. Years of experience of European and North American committee helped to set up such committees in Asia, Australia and Oceania, Central and South America (ECTRIMS, ACTRIMS, MENACTRIMS, PACTRIMS and LACTRIMS), Committees in individual countries. Russian Committee of the researchers of multiple sclerosis (RUCTRIMS) was established in 2010 with the support of the All-Russian Society of Neurologists, officially registered in 2012. First and Second Congress, held in 2013 in Kazan, and in 2015 in Yaroslavl, confirmed the high interest in this problem, which is associated with a significant improvement in understanding the mechanisms of development, diagnosis and treatment of MS and other demyelinating diseases. In 2017, new criteria for the diagnosis of MS were published, as well as the new European and Russian recommendations for MS treatment, new data on the diagnosis and treatment of NOM and other demyelinating diseases, atypical forms of MS. Now allowed and are actively introducing 15 products disease modifying therapy of MS (DMT), each of which has its own indications and contindications, advantages and disadvantages system of monitoring the efficacy, tolerability and safety, risk management plans. The completely stop the disease process is still not possible, in many cases, in the absence of adequate treatment, MS can lead to early disability in young adults. The main goal now is the personalized therapy, allowing early and accurately select the optimum method of pathogenetic treatment, develop a plan for the symptomatic treatment and rehabilitation. All it requires from neurologists and other professionals involved in MS care, additional knowledge in different topics. RUCTRIMS Congresses, attended by hundreds of doctors from Russia and other countries, have educational seminars, plenary sessions and symposiums in the programme with participation of leading neuroscientists, MS experts from more than 20 countries. We invite all those interested in this issue, to participate actively in the work of the 3rd RUCTRIMS Congress , which will be held in Ekaterinburg 14 - 16 September 2018 with the support of Russian Ministry of Health, the All-Russian Society neurologists, the Ministry of Health of the Sverdlovsk region and the Ural State Medical University.